NYSE:RVTYLife Sciences
Assessing Revvity (RVTY) Valuation After Signals BioDesign Launch And Earnings Anticipation
Product launch that is drawing fresh attention to Revvity (RVTY)
Revvity (RVTY) recently introduced Signals BioDesign, a cloud native molecular cloning platform aimed at biotech and pharma R&D teams. This launch is helping focus investor attention ahead of the upcoming earnings update.
See our latest analysis for Revvity.
At a share price of $92.90, Revvity has a 7 day share price return of 2.77% and a 30 day share price return of 7.42%. However, its 1 year total shareholder return of 0.63%...

